FindTrial
Sign In

Non-Compliance of CNS tumor patients to adjuvant treatment.

Non-Compliance to adjuvant radio(chemo)therapy and scheduled follow-up in patients with central nervous system tumors - CRIMSON

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068795
Enrollment
5000
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G969- Disorder of central nervous system, unspecified

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients who have been diagnosed with CNS tumors in TMC (TMH and ACTREC) and completed Radiation treatment.

Exclusion criteria

Exclusion criteria: Patients who did not undergo RT Patients who have been referred outside of TMC for follow-up.

Design outcomes

Primary

MeasureTime frame
To analyze the rate of noncompliance to adjuvant radio chemotherapy and scheduled follow-up in patients with central nervous system tumorsTimepoint: After the completion of therapy—

Secondary

MeasureTime frame
To determine the factors that cause noncompliance for the followup to adjuvant radiochemotherapy and scheduled follow-up in patients with central nervous system tumors. To analyse if the trial patients have a better follow up compliance rate then non trial patients. Timepoint: post radiotherapy completion—

Countries

India

Contacts

Public ContactDr Tejpal Gupta

Tata Memorial Hospital

tejpalgupta@rediffmail.com02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026